Here are relevant reports on : education-administration-market
-
Asia Pacific Identity and Access Management (IAM) Market by Solution, Service, Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type - Forecast to 2030
The identity and access management (IAM) market in the Asia Pacific region is projected to grow from USD 5.29 billion in 2025 to USD 9.55 billion by 2030, at a CAGR of 12.5% over the forecast period. Microsoft (US), IBM (US), Okta (US), Oracle (US Ping Identity (US), CyberArk (US), HID Global (US), NuSummit Cybersecurity (Aujas) (India), WSO2 (US), Wipro (India), Signzy (India), miniOrange (India), RSA Security (US), Delinea (US), ManageEngine (US), One Identity (US), and Auth0 (US) are the key players and other major players in the IAM market in Asia Pacific.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Property Management Market by Software Type (Lease Management (Portfolio Management, Document Storage & Management, AI Lease Abstraction, Lease Accounting & Administration), Facility Management, Reporting & Analytics), End User - Global Forecast to 2030
The property management market size is projected to reach USD 42.78 billion by 2030, at a CAGR of 8.3% during the forecast period. Some major players in the property management market include Oracle (US), IBM (US), Appfolio (US), SAP (Germany), Hitachi Vantara (US), Yardi (US), RealPage (US), SS&C (US), Trimble (US), Eptura (US), CoStar Group (US), Hemlane (US), Entrata (US), Rent Manager (US), Rentec Direct (US), Re-leased (UK), Doorloop (US), Stessa (US), JLL (US), MCS Rental Software (UK), Accruent (US), Planon (Netherlands), Guesty (Israel), Hive (Germany), Avail (Sweden), Property Matrix (US), HappyCo (US), Resman (US), Innago (US), Finquery (US), Rentredi (US), Turbotenant (US), Breezeway (US), Livly (US), SimplifyEm (US), Condo Control (US) and PayHOA (US)
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at USD 633.77 billion in 2024, stood at USD 690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD 1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
The Contrast Media market, valued at USD 7.65 billion in 2025, stood at USD 8.20 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 12.08 billion by the end of the period. Factors driving this growth include the increase in people with chronic conditions, like cardiovascular disease, cancer and neurological disorders, and, also, increase in the number of people getting diagnostic imaging tests on a global basis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market size is expected to reach USD 2,922.82 billion by 2031 from USD 2,152.45 billion in 2026, recording a CAGR of 6.3% during the forecast period. The Key Players Johnson & Johnson Services (US), Pfizer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Novartis AG (Switzerland), GSK plc (UK), AbbVie Inc. (US), Sanofi (France), Merck & Co., Inc. (US), and Amgen Inc. (US). Some of the prominent players operating in the global pharmaceutical drug delivery devices market include BD (US), Cardinal Health (US), SHL Medical (Switzerland), Gerresheimer AG (Germany), and Stevanato Group (Italy).
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type, Deployment Mode, Vertical - Global Forecast to 2030
The identity and access management (IAM) market is expected to grow from USD 25.96 billion in 2025 to USD 42.61 billion by 2030, at a compound annual growth rate (CAGR) of 10.4% during the forecast period. The Key Players Microsoft (US), Ping Identity (US), IBM (US), Okta (US), Oracle (US), SailPoint (US), Saviynt (US), CyberArk (US), Thales (France), Akamai Technologies (US), OpenText (Canada), Entrust (US), Duo Security (US), HID Global (US), Evidian (France), RSA Security (US), Avatier (US), ManageEngine (US), SecureAuth (US), EmpowerID (US), Simeio (US), One Identity (US), FusionAuth (US), Auth0 (US), IDnow (Germany), Zuora (US), Signzy (India), Civic Technologies (US), Trusona (US), Beyond Identity (US), Delinea (US), Optimal IdM (US), Netwrix (US), Aquera (US), Cerby (US), Traxion (Netherlands), Radiant Logic (US), Elimity (Belgium), Oleria (US), Veza (US), Bravura Security (Canada), Fischer Identity (US), Lumos (US), Omada (Denmark), OpenIAM (US), Pathlock (US), Tuebora (US), and Rippling (US)
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at USD10.94 billion in 2024, stood at USD11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of USD16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
